Your browser doesn't support javascript.
loading
Genetically engineered CAR NK cells display selective cytotoxicity against FLT3-positive B-ALL and inhibit in vivo leukemia growth.
Oelsner, Sarah; Waldmann, Anja; Billmeier, Arne; Röder, Jasmin; Lindner, Aline; Ullrich, Evelyn; Marschalek, Rolf; Dotti, Gianpietro; Jung, Gundram; Große-Hovest, Ludger; Oberoi, Pranav; Bader, Peter; Wels, Winfried S.
Afiliación
  • Oelsner S; Institute for Tumor Biology and Experimental Therapy, Georg-Speyer-Haus, Frankfurt, Germany.
  • Waldmann A; Institute for Tumor Biology and Experimental Therapy, Georg-Speyer-Haus, Frankfurt, Germany.
  • Billmeier A; Institute for Tumor Biology and Experimental Therapy, Georg-Speyer-Haus, Frankfurt, Germany.
  • Röder J; Institute for Tumor Biology and Experimental Therapy, Georg-Speyer-Haus, Frankfurt, Germany.
  • Lindner A; Frankfurt Cancer Institute, Goethe University, Frankfurt, Germany.
  • Ullrich E; Institute for Tumor Biology and Experimental Therapy, Georg-Speyer-Haus, Frankfurt, Germany.
  • Marschalek R; Division for Stem Cell Transplantation and Immunology, Hospital for Children and Adolescents, Goethe University, Frankfurt, Germany.
  • Dotti G; LOEWE Center for Cell and Gene Therapy, Goethe University, Frankfurt, Germany.
  • Jung G; Institute of Pharmaceutical Biology, Goethe University, Frankfurt, Germany.
  • Große-Hovest L; Lineberger Comprehensive Cancer Center and Department of Microbiology and Immunology, University of North Carolina, Chapel Hill, NC.
  • Oberoi P; Department of Immunology, Eberhard Karls University, Tübingen, Germany.
  • Bader P; German Cancer Consortium (DKTK), Partner Site Tübingen, Tübingen, Germany.
  • Wels WS; German Cancer Research Center (DKFZ), Heidelberg, Germany.
Int J Cancer ; 145(7): 1935-1945, 2019 10 01.
Article en En | MEDLINE | ID: mdl-30860598

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Células Asesinas Naturales / Leucemia-Linfoma Linfoblástico de Células Precursoras B / Inmunoterapia Adoptiva / Tirosina Quinasa 3 Similar a fms / Receptores Quiméricos de Antígenos Límite: Animals / Humans Idioma: En Revista: Int J Cancer Año: 2019 Tipo del documento: Article País de afiliación: Alemania

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Células Asesinas Naturales / Leucemia-Linfoma Linfoblástico de Células Precursoras B / Inmunoterapia Adoptiva / Tirosina Quinasa 3 Similar a fms / Receptores Quiméricos de Antígenos Límite: Animals / Humans Idioma: En Revista: Int J Cancer Año: 2019 Tipo del documento: Article País de afiliación: Alemania